QIAGEN Bags FDA Clearance of NeuMoDx CT/NG Assay for Both NeuMoDx 96 and 288 Molecular Systems
QIAGEN (NYSE:QGEN, Frankfurt Prime Standard: QIA)))) today announced the U.S. Food and Drug Administration (FDA) clearance for the NeuMoDx CT/NG Assay 2.0, growing its test menu for its integrated PCR-based clinical